Effect of long-acting versus short-acting glucagon-like peptide-1 receptor agonists on improving body weight and related metabolic parameters in type 2 diabetes: A head-to-head meta-analysis

BACKGROUND: Glucagon-like peptide-1 receptor agonists (GLP-1RAs) showed great value in treating nonalcoholic fatty liver disease (NAFLD). We aimed to compare the effectiveness of long-acting and short-acting GLP-1RAs on improving body weight and related metabolic parameters in patients with type 2 d...

Descripción completa

Detalles Bibliográficos
Autores principales: Yuan, Xia, Gao, Zhe, Hao, Zhihua, Ma, Huijuan, Duan, Kaixin, Yang, Caixuan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Lippincott Williams & Wilkins 2023
Materias:
4300
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10615555/
https://www.ncbi.nlm.nih.gov/pubmed/37904378
http://dx.doi.org/10.1097/MD.0000000000035739

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10615555/
https://www.ncbi.nlm.nih.gov/pubmed/37904378
http://dx.doi.org/10.1097/MD.0000000000035739

Ejemplares similares